Answers are grounded in this paper and cite their sources.
Shows improved CGM access for adults with uncontrolled diabetes, indicating a pathway to health equity.
PURPOSE: To describe the implementation and outcomes of a pharmacist-led initiative designed to improve access to continuous glucose monitoring (CGM) technology for adults with uncontrolled type 2 diabetes at a Federally Qualified Health Center (FQHC). SUMMARY: Uncontrolled diabetes remains highly prevalent among underserved populations and contributes to major health disparities. CGM can enhance glycemic control and patient engagement, yet in resource-limited communities access remains a major issue. Pharmacists are positioned to address these disparities by facilitating education, device access, and insurance navigation. CONCLUSION: Pharmacist-led interventions at an FQHC substantially improved access to CGM devices for patients with uncontrolled diabetes. Through direct education, payor navigation, and device coordination, pharmacists mitigated common financial and logistical barriers to care. This model offers a potential scalable strategy to advance health equity in access to diabetes technology.
No takes yet. Share an insight, caveat, or question.
Pashaeimofrad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: